118 related articles for article (PubMed ID: 9831484)
1. MVLN cells: a bioluminescent MCE-7-derived cell line to study the modulation of estrogenic activity.
Demirpence E; Duchesne MJ; Badia E; Gagne D; Pons M
J Steroid Biochem Mol Biol; 1993 Sep; 46(3):355-64. PubMed ID: 9831484
[TBL] [Abstract][Full Text] [Related]
2. Long-term hydroxytamoxifen treatment of an MCF-7-derived breast cancer cell line irreversibly inhibits the expression of estrogenic genes through chromatin remodeling.
Badia E; Duchesne MJ; Semlali A; Fuentes M; Giamarchi C; Richard-Foy H; Nicolas JC; Pons M
Cancer Res; 2000 Aug; 60(15):4130-8. PubMed ID: 10945620
[TBL] [Abstract][Full Text] [Related]
3. Antiestrogenic effects of all-trans-retinoic acid and 1,25-dihydroxyvitamin D3 in breast cancer cells occur at the estrogen response element level but through different molecular mechanisms.
Demirpence E; Balaguer P; Trousse F; Nicolas JC; Pons M; Gagne D
Cancer Res; 1994 Mar; 54(6):1458-64. PubMed ID: 8137248
[TBL] [Abstract][Full Text] [Related]
4. Stable luciferase transfected cells for studying steroid receptor biological activity.
Gagne D; Balaguer P; Demirpence E; Chabret C; Trousse F; Nicolas JC; Pons M
J Biolumin Chemilumin; 1994; 9(3):201-9. PubMed ID: 7942125
[TBL] [Abstract][Full Text] [Related]
5. Screening for estrogenicity and anti-estrogenicity: a critical evaluation of an MVLN cell-based transactivation assay.
Freyberger A; Schmuck G
Toxicol Lett; 2005 Jan; 155(1):1-13. PubMed ID: 15585354
[TBL] [Abstract][Full Text] [Related]
6. Development and characterization of a cell line that stably expresses an estrogen-responsive luciferase reporter for the detection of estrogen receptor agonist and antagonists.
Wilson VS; Bobseine K; Gray LE
Toxicol Sci; 2004 Sep; 81(1):69-77. PubMed ID: 15166400
[TBL] [Abstract][Full Text] [Related]
7. In vivo bioluminescence imaging to evaluate estrogenic activities of endocrine disrupters.
Pillon A; Servant N; Vignon F; Balaguer P; Nicolas JC
Anal Biochem; 2005 May; 340(2):295-302. PubMed ID: 15840503
[TBL] [Abstract][Full Text] [Related]
8. A new cellular model of response to estrogens: a bioluminescent test to characterize (anti) estrogen molecules.
Pons M; Gagne D; Nicolas JC; Mehtali M
Biotechniques; 1990 Oct; 9(4):450-9. PubMed ID: 2257144
[TBL] [Abstract][Full Text] [Related]
9. Hydroxytamoxifen induces a rapid and irreversible inactivation of an estrogenic response in an MCF-7-derived cell line.
Badia E; Duchesne MJ; Fournier-Bidoz S; Simar-Blanchet AE; Terouanne B; Nicolas JC; Pons M
Cancer Res; 1994 Nov; 54(22):5860-6. PubMed ID: 7954415
[TBL] [Abstract][Full Text] [Related]
10. Study of an antiestrogenic effect of retinoic acid in MCF-7 cells.
Demirpence E; Pons M; Balaguer P; Gagne D
Biochem Biophys Res Commun; 1992 Feb; 183(1):100-6. PubMed ID: 1543480
[TBL] [Abstract][Full Text] [Related]
11. [Antiestrogenic effect of retinoic acid in MCF-7 cells].
Demirpence E; Pons M; Balaguer P; Gagne D
C R Seances Soc Biol Fil; 1991; 185(6):444-55. PubMed ID: 1822393
[TBL] [Abstract][Full Text] [Related]
12. Steroidal affinity labels of the estrogen receptor. 3. Estradiol 11 beta-n-alkyl derivatives bearing a terminal electrophilic group: antiestrogenic and cytotoxic properties.
Lobaccaro C; Pons JF; Duchesne MJ; Auzou G; Pons M; Nique F; Teutsch G; Borgna JL
J Med Chem; 1997 Jul; 40(14):2217-27. PubMed ID: 9216841
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of creatine kinase specific activity in human osteoblast and endometrial cells by estrogens and anti-estrogens and its modulation by calciotropic hormones.
Fournier B; Häring S; Kaye AM; Sömjen D
J Endocrinol; 1996 Aug; 150(2):275-85. PubMed ID: 8869594
[TBL] [Abstract][Full Text] [Related]
14. Nomegestrol acetate, a clinically useful 19-norprogesterone derivative which lacks estrogenic activity.
Catherino WH; Jordan VC
J Steroid Biochem Mol Biol; 1995 Nov; 55(2):239-46. PubMed ID: 7495704
[TBL] [Abstract][Full Text] [Related]
15. Development of a stably transfected estrogen receptor-mediated luciferase reporter gene assay in the human T47D breast cancer cell line.
Legler J; van den Brink CE; Brouwer A; Murk AJ; van der Saag PT; Vethaak AD; van der Burg B
Toxicol Sci; 1999 Mar; 48(1):55-66. PubMed ID: 10330684
[TBL] [Abstract][Full Text] [Related]
16. Estrogenic/antiestrogenic and scavenging properties of (E)- and (Z)-resveratrol.
Basly JP; Marre-Fournier F; Le Bail JC; Habrioux G; Chulia AJ
Life Sci; 2000 Jan; 66(9):769-77. PubMed ID: 10698352
[TBL] [Abstract][Full Text] [Related]
17. Estrogenic activity of the phytoestrogens naringenin, 6-(1,1-dimethylallyl)naringenin and 8-prenylnaringenin.
Zierau O; Gester S; Schwab P; Metz P; Kolba S; Wulf M; Vollmer G
Planta Med; 2002 May; 68(5):449-51. PubMed ID: 12058324
[TBL] [Abstract][Full Text] [Related]
18. Recombinant cell bioassays for endocrine disruptors: development of a stably transfected human ovarian cell line for the detection of estrogenic and anti-estrogenic chemicals.
Rogers JM; Denison MS
In Vitr Mol Toxicol; 2000; 13(1):67-82. PubMed ID: 10900408
[TBL] [Abstract][Full Text] [Related]
19. Indolo[3,2-b]carbazole: a dietary-derived factor that exhibits both antiestrogenic and estrogenic activity.
Liu H; Wormke M; Safe SH; Bjeldanes LF
J Natl Cancer Inst; 1994 Dec; 86(23):1758-65. PubMed ID: 7966413
[TBL] [Abstract][Full Text] [Related]
20. Estrogenic and antiproliferative activities on MCF-7 human breast cancer cells by flavonoids.
Le Bail JC; Varnat F; Nicolas JC; Habrioux G
Cancer Lett; 1998 Aug; 130(1-2):209-16. PubMed ID: 9751276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
